Therapeutic Agents Comprising Pro-Apoptotic Proteins
AssigneeResearch Development Foundation
InventorsMichael G. Rosenblum, Yuying Liu
Life of this patent
Estimating the term…
Abstract
The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.
Claims6
A chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor.
-24. (canceled)
An expression cassette comprising a polynucleotide encoding a chimeric polypeptide comprising a cell-specific targeting moiety and an apoptosis-inducing factor, wherein said apoptosis-inducing factor is a granzyme, and wherein said polynucleotide is under control of a regulatory sequence operable in a host cell.
-31. (canceled)
A host cell comprising an expression cassette comprising a polynucleotide encoding a chimeric polypeptide comprising a cell-specific targeting moiety and an apoptosis-inducing factor, wherein said apoptosis-inducing factor is a granzyme.
-61. (canceled)
Dependencies are inferred from the claim text.